Placebo: Clinical Trials

5 trials for Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Active not recruiting 1, Recruiting 1
Phase 12Active not recruiting 1, Recruiting 1

Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels
Low-intensity TMS, Transcranial Magnetic Stimulation Sham - Depression - Major Depressive Disorder, Transcranial Magnetic Stimulation
Phase 1 / Phase 2RecruitingUniversidad de Guanajuato402024-10-282025-05-08
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
Suvorexant, Placebo - Suvorexant, Placebo
Phase 2CompletedJohns Hopkins University762022-03-302026-08-10
Neural Correlates of Hypoalgesia Driven by Observation
Naloxone, Saline - Pain, Virtual Reality
Phase 2CompletedUniversity of Maryland, Baltimore2112021-11-012026-04-16
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
Active Virtual Reality, sham Virtual Reality, No Intervention - Pain, Virtual Reality
Phase 1 / Phase 2Active not recruitingUniversity of Maryland, Baltimore2592021-11-012026-02-27
The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
d-cycloserine, Sugar Pill - Treatment, Placebo
Phase 2CompletedHartford Hospital512008-01-012021-02-18

Narrower conditions

Pain (2)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Opioid-Related Disorders (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Temporomandibular Joint Disorders (1)

Broader conditions

Mental Disorders (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Chemically-Induced Disorders (1)  ·  Craniomandibular Disorders (1)  ·  Depressive Disorder (1)  ·  Dyssomnias (1)  ·  Jaw Diseases (1)  ·  Joint Diseases (1)  ·  Mandibular Diseases (1)  ·  Mood Disorders (1)  ·  Muscular Diseases (1)

Interventions

Naloxone (2)  ·  Sodium Chloride (2)  ·  Cycloserine (1)  ·  Exergaming (1)  ·  Sugars (1)  ·  suvorexant (1)

Sponsors

University of Maryland, Baltimore (2)  ·  Hartford Hospital (1)  ·  Johns Hopkins University (1)  ·  Universidad de Guanajuato (1)

Countries

United States (4)  ·  Mexico (1)

Top investigators

Luana Colloca, MD/PhD/MS (2)  ·  Andrew S Huhn, Ph.D. (1)  ·  Gretchen J. Diefenbach, Ph.D. (1)  ·  Ma. Eugenia Garay Sevilla, PhD in medical sciences (1)  ·  Olga E Escobar Florez, Master of Medical Sciences (1)

NIH funding

UH3DA048734 (1)